Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC

PaperCitations, authors & open-access status

Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 630 citations, 2023 year and closed oa status.

630
Citations
2023
Year
closed
OA Status

Related on ScholarIQ

Jonathan W. Goldman
Author
Frances A. Shepherd
Author
Christian Grohé
Author
Yi‐Long Wu
Author
New England Journal of Medicine
Journal
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account